(Q40432890)

20 September 2017

Effects of melatonin on wortmannin-induced tau hyperphosphorylation (English)

1 reference

20 September 2017

0 references

Yan-qiu Deng

1

1 reference

20 September 2017

Guo-gang Xu

2

1 reference

20 September 2017

Ping Duan

3

1 reference

20 September 2017

Qi Zhang

4

1 reference

20 September 2017

Jian-zhi Wang

5

1 reference

20 September 2017

1 May 2005

1 reference

Acta Pharmacologica Sinica

20 September 2017

1 reference

20 September 2017

26

1 reference

20 September 2017

5

1 reference

20 September 2017

519-526

1 reference

https://scigraph.springernature.com/pub.10.1111/j.1745-7254.2005.00102.x

20 September 2017

0 references

cites work

Neurodegenerative tauopathies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Glycogen synthase kinase 3: a drug target for CNS therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

GSK3beta signalling: casting a wide net in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Melatonin protects SH-SY5Y neuroblastoma cells from calyculin A-induced neurofilament impairment and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Melatonin attenuates isoproterenol-induced protein kinase A overactivation and tau hyperphosphorylation in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Melatonin reduces X-ray irradiation-induced oxidative damages in cultured human skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Glycogen synthase kinase-3 beta-mediated tau phosphorylation in cultured cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Glycogen synthase kinase 3: an emerging therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Effect of amyloid peptides on serum withdrawal-induced cell differentiation and cell viability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Cytoskeletal mechanisms of neuronal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Cultured neurons expressing phosphorylated tau are more resistant to apoptosis induced by NMDA or serum deprivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Cell death mechanisms in neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Neuroscience. New leads on the 'how' of Alzheimer's.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Antioxidant strategies for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Comparison of melatonin versus vitamin C on oxidative stress and antioxidant enzyme activity in Alzheimer's disease induced by okadaic acid in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Melatonin: reducing the toxicity and increasing the efficacy of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

Expression of membrane and nuclear melatonin receptors in mouse peripheral organs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00102.X

10.1111/J.1745-7254.2005.00102.X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference